Ultrarush versus semirush venom immunotherapy: Outcome observations in real-world jack jumper ant cohort

J Allergy Clin Immunol Pract. 2024 Sep;12(9):2527-2529.e1. doi: 10.1016/j.jaip.2024.05.032. Epub 2024 May 27.

Authors

Kymble Spriggs¹, Elizabeth Leahy², Nicole Weibel², Emily Heke², Sara Barnes³

Affiliations

¹ Allergy & Immunology, Monash Health, Clayton, VIC, Australia; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia. Electronic address: [email protected].
² Allergy & Immunology, Monash Health, Clayton, VIC, Australia.
³ Allergy & Immunology, Monash Health, Clayton, VIC, Australia; Department of Medicine, Monash University, Clayton, VIC, Australia.

PMID: 38810692
DOI: 10.1016/j.jaip.2024.05.032

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Allergens / immunology
Animals
Ant Venoms* / immunology
Ant Venoms* / therapeutic use
Ants* / immunology
Cohort Studies
Desensitization, Immunologic* / methods
Female
Humans
Hypersensitivity / therapy
Insect Bites and Stings* / immunology
Male
Middle Aged
Treatment Outcome
Young Adult

Substances

Ant Venoms
Allergens